The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer-Reference-Cited by-同舟云学术

The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer

Published:2017-06-13 Issue:18 Volume:123 Page:3532-3539
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Pomerantz Mark M.¹^ORCID,Spisák Sandor¹,Jia Li²,Cronin Angel M.³,Csabai Istvan⁴,Ledet Elisa⁵,Sartor A. Oliver⁵,Rainville Irene³,O'Connor Edward P.¹,Herbert Zachary T.¹,Szállási Zoltan⁶,Oh William K.⁷,Kantoff Philip W.⁸,Garber Judy E.³,Schrag Deborah³,Kibel Adam S.²,Freedman Matthew L.¹

Affiliation:

1. Department of Medical Oncology; Dana-Farber Cancer Institute; Boston Massachusetts

2. Department of Surgery, Division of Urology; Brigham and Women's Hospital; Boston Massachusetts

3. Division of Population Sciences; Dana-Farber Cancer Institute; Boston Massachusetts

4. Department of Physics of Complex Systems Eotvos Lorand University; Budapest Hungary

5. Department of Medicine; Tulane Cancer Center; New Orleans Louisiana

6. Department of Pediatrics; Boston Children's Hospital; Boston Massachusetts

7. Department of Medicine, Division of Hematology and Oncology; Tisch Cancer Institute; New York New York

8. Department of Medicine; Memorial Sloan Kettering Cancer Institute; New York New York

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. Cancer risks in BRCA2 mutation carriers;Breast Cancer Linkage Consortium;J Natl Cancer Inst.,1999

2. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary;Asperen;J Med Genet.,2005

3. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients;Kote-Jarai;Br J Cancer.,2011

4. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer;Gallagher;Clin Cancer Res.,2010

5. Prostate cancer progression and survival in BRCA2 mutation carriers;Tryggvadottir;J Natl Cancer Inst.,2007

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in platinum chemotherapy for metastatic castration-resistant prostate cancer: Insights and perspectives;Cancer Treatment Reviews;2024-11

2. Genetics of prostate cancer: a review of latest evidence;Journal of Medical Genetics;2024-08-13

3. Personalized treatment using predictive biomarkers in solid organ malignancies: A review;Tumori Journal;2024-08-02

4. DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes;JCO Precision Oncology;2024-08

5. BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients;JAMA Oncology;2024-07-25